Zhao Chuan, Liu Siyuan, Dang Wenya, Liu Qing, Yin Danni, Liu Bin, Hou Chunsheng
Institute of Bast Fiber Crops, Chinese Academy of Agricultural Sciences, Changsha 410000, China.
College of Chemistry and Chemical Engineering, Hunan University, Changsha 410012, China.
Anal Chem. 2025 Aug 5;97(30):16690-16697. doi: 10.1021/acs.analchem.5c03866. Epub 2025 Jul 26.
Precise identification of tumors is crucial for early diagnosis and treatment of cancer. However, spatially specific and sensitive molecular imaging of tumors remains a challenge due to issues such as low biomarker content and extra-tumor signal leakage. Endogenous purine/pyrimidine endonuclease 1 (APE1) is a marker for tumor diagnosis by detecting activity change and translocation from the nucleus into the cytoplasm. In this work, we developed a biosensor (named DNA/ZIF-8@Protein NPs) based on biomineralized metal-organic framework nanoparticles (MOF NPs) for sensitive detection and imaging of APE1 with the assistance of the rolling circle amplification reaction (RCA). In vitro experiments showed that based on the sensitivity of APE1 imaging, this biosensor can detect APE1 in the range of 0.005 to 2 U/mL with a detection limit of 0.0005 U/mL under optimal conditions. Functional probes and phi29 were loaded with ZIF-8, ensuring their simultaneous delivery to living cells. The results of in vivo experiments show that these DNA/ZIF-8@Protein NPs enable precise tumor cell identification and ultrasensitive molecular in situ tumor imaging by monitoring intracellular APE1. In summary, this method based on enzyme-activated RCA reaction provides new opportunities for ultrasensitive tumor in situ molecular imaging of tumor markers.
肿瘤的精确识别对于癌症的早期诊断和治疗至关重要。然而,由于生物标志物含量低和肿瘤外信号泄漏等问题,肿瘤的空间特异性和灵敏分子成像仍然是一项挑战。内源性嘌呤/嘧啶内切酶1(APE1)是一种通过检测活性变化以及从细胞核向细胞质的转位来用于肿瘤诊断的标志物。在这项工作中,我们基于生物矿化金属有机框架纳米颗粒(MOF NPs)开发了一种生物传感器(命名为DNA/ZIF-8@Protein NPs),用于在滚环扩增反应(RCA)的辅助下对APE1进行灵敏检测和成像。体外实验表明,基于APE1成像的灵敏度,该生物传感器在最佳条件下能够检测0.005至2 U/mL范围内的APE1,检测限为0.0005 U/mL。功能探针和phi29被装载到ZIF-8中,确保它们能同时递送至活细胞。体内实验结果表明,这些DNA/ZIF-8@Protein NPs通过监测细胞内APE1实现了精确的肿瘤细胞识别和超灵敏的肿瘤分子原位成像。总之,这种基于酶激活RCA反应的方法为肿瘤标志物的超灵敏肿瘤原位分子成像提供了新的机遇。